Word

X PARSOLEX PARTNER SOLUTIONS EXCELLENCE

Status

Registered

Status Code

700

Status Date

Tuesday, May 18, 2021

Serial Number

88570495

Registration Number

6356728

Registration Date

Tuesday, May 18, 2021

Mark Type

3000

Filing Date

Wednesday, August 7, 2019

Published for Opposition

Tuesday, July 28, 2020

Trademark Owner History

Parsolex GMP Center, Inc. - Original Registrant

Classifications

35 Market assessment services; consulting services, namely, providing market research and business analysis services in the pharmaceutical, medical and healthcare fields; business consulting and planning services in the field of pharmaceuticals, medicine and healthcare; business consulting and planning services in the field of the commercialization of pharmaceuticals, medicines and healthcare products; business consulting services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and production systems and distribution solutions; consulting in the fields of sales methods, sales management, and sales improvement; business consultation; business administration consultation services; business operation consultation services; business consulting services in the field of pharmaceutical manufacturing, pharmaceutical packaging, and distribution; business consulting in the pharmaceutical products, medical and healthcare industries; business consulting, business management, business advisory services; marketing consulting services in the field of pharmaceuticals, medicine and healthcare; business marketing consulting services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; branding and marketing services for others in the field of pharmaceutical, medical, and healthcare industries; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; advertising of custom services for pharmaceutical formulation design, design of processes to transform inorganic and organic substances, scale-up of pharmaceutical manufacturing processes, pharmaceutical technology transfer, manufacture of pharmaceuticals, and chemical and physical evaluation of pharmaceuticals for others; distributorship services of pharmaceutical and medical products for others; commercialization of pharmaceuticals and medical products for others

45 Consulting services in the field of regulatory compliance in the pharmaceutical, medical and healthcare industries; regulatory services for others, namely, tracking and monitoring regulatory requirements in the field of the pharmaceutical, medical, and healthcare industries for regulatory compliance purposes

The mark consists of a stylized design comprised of two diagonal intersecting pill capsules forming a heart shaped arrow design on the left side and creating an "x" shape; the design element appears to the left of the wording "Parsolex"; centered underneath the design and "Parsolex" wording appears the wording "PARTNER SOLUTIONS EXCELLENCE".
Color is not claimed as a feature of the mark.
"SOLUTIONS"

Trademark Events

May 18, 2021

Registered-Principal Register

Apr 16, 2021

Notice Of Acceptance Of Statement Of Use E-Mailed

Apr 15, 2021

Allowed Principal Register - Sou Accepted

Apr 2, 2021

Statement Of Use Processing Complete

Mar 17, 2021

Use Amendment Filed

Apr 1, 2021

Case Assigned To Intent To Use Paralegal

Mar 17, 2021

Teas Statement Of Use Received

Sep 22, 2020

Noa E-Mailed - Sou Required From Applicant

Jul 28, 2020

Official Gazette Publication Confirmation E-Mailed

Jul 28, 2020

Published For Opposition

Jul 8, 2020

Notification Of Notice Of Publication E-Mailed

Jun 24, 2020

Law Office Publication Review Completed

Jun 16, 2020

Approved For Pub - Principal Register

Jun 16, 2020

Examiner's Amendment Entered

Jun 16, 2020

Notification Of Examiners Amendment E-Mailed

Jun 16, 2020

Examiners Amendment E-Mailed

Jun 16, 2020

Examiners Amendment -Written

Jun 10, 2020

Previous Allowance Count Withdrawn

May 5, 2020

Withdrawn From Pub - Og Review Query

Apr 22, 2020

Approved For Pub - Principal Register

Apr 22, 2020

Examiner's Amendment Entered

Apr 22, 2020

Notification Of Examiners Amendment E-Mailed

Apr 22, 2020

Examiners Amendment E-Mailed

Apr 22, 2020

Examiners Amendment -Written

Apr 16, 2020

Teas/Email Correspondence Entered

Apr 16, 2020

Correspondence Received In Law Office

Apr 15, 2020

Assigned To Lie

Apr 8, 2020

Teas Response To Office Action Received

Oct 31, 2019

Notification Of Priority Action E-Mailed

Oct 31, 2019

Priority Action E-Mailed

Oct 31, 2019

Priority Action Written

Oct 16, 2019

Assigned To Examiner

Aug 27, 2019

Notice Of Design Search Code E-Mailed

Aug 24, 2019

New Application Office Supplied Data Entered

Aug 10, 2019

New Application Entered